Chugai Pharmaceutical Co., Ltd.
Symbole: 4519.T
JPX
5436
JPYPrix du marché aujourd'hui
24.8333
Ratio P/E
1.0557
Ratio PEG
8.94T
Cap MRK
- 0.02%
Rendement DIV
Chugai Pharmaceutical Co., Ltd. (4519-T) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 2787296 | 738982 | 503107 | 471970 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 1169402 | 280308 | 280938 | 204217 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 1175428 | 320348 | 514283 | 356009 | |||||||||||||||||||||
balance-sheet.row.inventory | 1094030 | 273480 | 292206 | 208838 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 161328 | 33616 | 26941 | 26844 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 5218082 | 1366426 | 1336537 | 1063661 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1670723 | 420701 | 386651 | 352107 | |||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 80088 | 19860 | 25141 | 21974 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 80088 | 19860 | 25141 | 21974 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 10984 | 1254 | -279101 | -201824 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 263786 | 64474 | 65244 | 56287 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 235887 | 59832 | 335286 | 246489 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 2261468 | 566121 | 533221 | 475033 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 7479550 | 1932547 | 1869758 | 1538694 | |||||||||||||||||||||
balance-sheet.row.account-payables | 353134 | 54234 | 209835 | 152266 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 6975 | 6975 | 6434 | 6550 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 140811 | 40798 | 98543 | 86312 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 6480 | 6480 | -430 | -490 | |||||||||||||||||||||
Deferred Revenue Non Current | 378 | 378 | 430 | 490 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 20615 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 729647 | 226977 | 207382 | 168520 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 73820 | 18749 | 21641 | 23255 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 29351 | 6480 | 7675 | 9490 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1163607 | 306966 | 445371 | 350677 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 292808 | 73202 | 73202 | 73202 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 5765677 | 1488738 | 1293352 | 1054050 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -19740 | -5714 | -10972 | -7457 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 277198 | 69354 | 68805 | 68222 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 6315943 | 1625580 | 1424387 | 1188017 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 7479550 | 1932546 | 1869758 | 1538694 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 6315943 | 1625580 | 1424387 | 1188017 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 7479550 | - | - | - | |||||||||||||||||||||
Total Investments | 1170656 | 281562 | 1837 | 2393 | |||||||||||||||||||||
balance-sheet.row.total-debt | 36326 | 13455 | 14109 | 16040 | |||||||||||||||||||||
balance-sheet.row.net-debt | -1581568 | -445219 | -208060 | -251713 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 398330 | 325472 | 575875 | 470367 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2700 | 31740 | 31434 | 30868 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | 50548 | 130634 | -183311 | -83122 | |||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 50548 | 130634 | -183311 | -83122 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | -66477 | -76520 | -179886 | -138487 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 384301 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -59603 | -74258 | -71239 | -72866 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | 17093 | 19346 | 1048 | 6897 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | -569376 | -545983 | -519002 | -372264 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 574541 | 546962 | 442919 | 325028 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | -17977 | 15161 | 280 | -5722 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -35455 | -38772 | -145994 | -118927 | |||||||||||||||||||||
cash-flows.row.debt-repayment | -5842 | -7863 | 0 | -9079 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | 171 | 217 | 241 | 322 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -7 | -5 | -5 | -8 | |||||||||||||||||||||
cash-flows.row.dividends-paid | -131188 | -131594 | -138220 | -98644 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | -1954 | -5 | -7657 | 1 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -138841 | -139250 | -145641 | -107408 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 5171 | 3202 | 1939 | 2128 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | 215177 | 236505 | -45584 | 55420 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1617894 | 458674 | 222169 | 267753 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1402717 | 222169 | 267753 | 212333 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 384301 | 411326 | 244112 | 279626 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -59603 | -74258 | -71239 | -72866 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 324698 | 337068 | 172873 | 206760 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1036075 | 1111367 | 1259946 | 999759 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 334928 | 418358 | 476251 | 338147 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 701147 | 693009 | 783695 | 661612 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 173268 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | -6604 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 114150 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | -1394 | 0 | -2134 | -2540 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 265960 | 277344 | 250386 | 239715 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 600888 | 695702 | 726637 | 577862 | |||||||||||||||||||||
income-statement-row.row.interest-income | 1411 | 1482 | 182 | 166 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24 | 27 | 61 | 48 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 114150 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 8859 | 28156 | -2143 | -2512 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -1394 | 0 | -2134 | -2540 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 8859 | 28156 | -2143 | -2512 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24 | 27 | 61 | 48 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 4183 | 31740 | -2082 | -2464 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 439372 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 435189 | 415665 | 533309 | 421897 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 444048 | 443821 | 531166 | 419385 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 117676 | 118349 | 156737 | 116390 | |||||||||||||||||||||
income-statement-row.row.net-income | 326373 | 325472 | 374429 | 302995 |
Questions fréquemment posées
Quel est le total de Chugai Pharmaceutical Co., Ltd. (4519.T) de l'actif total?
Chugai Pharmaceutical Co., Ltd. (4519.T) Le total des actifs est 1932547000000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 510761000000.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.677.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 197.344.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.315.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.420.
Qu'est-ce que Chugai Pharmaceutical Co., Ltd. (4519.T) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 325472000000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 13455000000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 277344000000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 462863000000.000.